Introduction: There is limited empirical evidence on patients' and healthcare professionals' views on the provision of pharmacogenetic testing services. These opinions may be used to shape the development of emerging pharmacogenetic services and inform healthcare professionals' future educational requirements.
Objectives: To explore patients' and healthcare professionals' views about pharmacogenetic testing services and their future development.